EMA publishes new document on regulatory procedural advice on biosimilars

April 12, 2012 9:01 AM

The European Medicines Agency has published a new document on regulatory procedural advice on similar biological medicines.

The guidance brings together in a single place a number of regulatory and procedural questions already published on the Agency’s website in existing regulatory documents. It complements existing guidance documents on innovative products and should be read in conjunction with the Agency’s scientific guidelines on biosimilars.

The Agency is responsible for assessing applications from companies to market biological medicines for use in the European Union (EU), including biosimilar medicines within the framework of the centralised authorisation procedure.

The updated document can be accessed from here:

Source: EMA

 

Leave a Reply

Twitter ID
(ID only. No links or "@" symbols)


Latest News on Biosimilar News

Share an Article?

Writing an article is not only a great way to share your knowledge, but it is also a great way to give back to the community.

We value all our contributors and if you have a website, we will surely give a link back to your site and products.
Wanna contribute?

Suggestions?

Biosimilar News was started for the people who are interested in this rapidly growing business area. So if you have suggestions or feedback on how we can improve, please let us know. If you want to see a specific topic covered, answer to a specific question, or anything else of this sort, just write us. We do our best to keep up!
Make a suggestion now!